SA

Sharda Appa Pawar

Active Director Director DIN 08286270
DIN 08286270 First appointment Nov 2018 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2018
Shareholding value •••• Premium profile

About Sharda Appa Pawar

Data last updated:

Sharda Appa Pawar is a Director at Miliorism Pharma Private Limited (since 2018). The company operates in Chemicals. Miliorism Pharma Private Limited reported revenue of ₹26.3 Lakh (FY 2025).

DIN 08286270
Primary Designation Director
Industry Chemicals
First Appointment 26 Nov 2018
Oldest Company Age 7 yrs
Largest company Miliorism Pharma Private Limited · ₹26.3 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Miliorism Pharma Private Limited U24230PN2018PTC180343
Director26 Nov 20182018₹26.3 Lakh (FY 2025)Active

Board colleagues of Sharda Appa Pawar

Directorship timeline

Open interactive timeline →
Miliorism Pharma Private Limited
Premium access

Shareholding and investment profile for Sharda Appa Pawar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sharda Appa Pawar

Sharda Appa Pawar currently holds 1 directorship: Miliorism Pharma Private Limited (Director, since 26 Nov 2018, revenue ₹26.3 Lakh (FY 2025)).

Sharda Appa Pawar was first appointed on 26 Nov 2018 as Director at Miliorism Pharma Private Limited.

The current boards of Sharda Appa Pawar's companies include Dilip Appa Pawar (Miliorism Pharma Private Limited), Kaveri Dilip Pawar (Miliorism Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available